Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.
Business Model:
Revenue: $20.3M
Employees: 51-200
Address: 2 Corporate Dr
City: South San Francisco
State: CA
Zip: 94080
Country: US
Trellis Bioscience develops a technology platform for cellular informatics. The company&s;s technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
Contact Phone:
+16506161100
Contact Email:
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2004 | Series A | $3.4M | 11/2011 | Debt Financing | $235k | 2/2007 | Series B | 4 | $10M |
Easton Capital Morgenthaler Ventures Novartis Venture Fund Pac-Link Easton Capital Morgenthaler Ventures Novartis Venture Fund Pac-Link |
10/2019 | Grant | 1 | $3.2M |
CARB-X CARB-X |
8/2009 | Venture Round | $11.7M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|